Metabolic Management of insulin resistance and diabesity Filomena Trindade, MD, MPH Effect of Dietary Lipids on the Gut Microbiome: What Do We Know? Angela Zivkovic, PhD Aspirin Effectiveness and its Influence on Cardiovascular Risk Jeffrey Boone, M.D. The Microbiome and Cardiovascular Disease Thomas Sult, MD Pharmacological Principles of Treating Type 1 Diabetes Mellitus Blair Geho, MD, PhD The Human Microbiome in Health and Disease Robert Rountree, MD Tame the Flames of PCOS: A Unique Integrative Approach Felice Gersh, MD Why We Get Fat?: An Alternative Hypothesis of Obesity Gary Taubes « Page 1 » CME Webcasts Sleep Health: Healthy Sleep, Healthy Heart The Role of Adverse Pregnancy Outcomes in Heart Disease Prevention Identifying Subclinical Cardiovascular Disease Aggressive Detection and Reversal of Heart Disease The Impact of Periodontal Disease on Metabolic and Cardiovascular Disease News You Can Use New Study Shows Portfolio Diet Lowers BP (in addition to LDL-C & hsCRP) Study Shows Colchicine Use in Patients with Gout May Reduce Cardiovascular Event Rates Patients with Nonalcoholic Fatty Liver Disease May Warrant Additional CV Risk Assessment New Recommendations for Vitamin D Testing NT-proBNP as a Predictor of Heart Failure in Patients with Chronic Kidney Disease
